A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates
Clinical trial NCT06632990 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06632990
- Sponsor
- Allyx Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2025-04-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.